Agios Pharmaceuticals AGIO Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agios Pharmaceuticals's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Agios Pharmaceuticals's short-term investments?
- Agios Pharmaceuticals (AGIO) reported short-term investments of $623.44M in Q1 2026.
- How has Agios Pharmaceuticals's short-term investments changed year-over-year?
- Agios Pharmaceuticals's short-term investments decreased by 23.4% year-over-year, from $814.41M to $623.44M.
- What is the long-term trend for Agios Pharmaceuticals's short-term investments?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's short-term investments has grown at a 11.4% compound annual growth rate (CAGR), from $445.49M to $765.3M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.